Works matching IS 20590105 AND DT 2023
Results: 200
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00781-0
- By:
- Publication type:
- Article
Subunit nanovaccine elicited T cell functional activation controls Trypanosoma cruzi mediated maternal and placental tissue damage and improves pregnancy outcomes in mice.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00782-z
- By:
- Publication type:
- Article
Healthy ageing: Herpes zoster infection and the role of zoster vaccination.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00757-0
- By:
- Publication type:
- Article
A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00786-9
- By:
- Publication type:
- Article
Pfs230 Domain 7 is targeted by a potent malaria transmissionblocking monoclonal antibody.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00784-x
- By:
- Publication type:
- Article
Author Correction: A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00790-z
- By:
- Publication type:
- Article
Conjugation of HIV-1 envelope to hepatitis B surface antigen alters vaccine responses in rhesus macaques.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00775-y
- By:
- Publication type:
- Article
Outlook of pandemic preparedness in a post-COVID-19 world.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00773-0
- By:
- Publication type:
- Article
Enhancing anti-viral neutralization response to immunization with HIV-1 envelope glycoprotein immunogens.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00774-z
- By:
- Publication type:
- Article
Ischemic stroke after COVID-19 bivalent vaccine administration in patients aged 65 years and older in the United States.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00777-w
- By:
- Publication type:
- Article
BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00779-8
- By:
- Publication type:
- Article
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00776-x
- By:
- Publication type:
- Article
The effect of dosage on the protective efficacy of whole-sporozoite formulations for immunization against malaria.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00778-9
- By:
- Publication type:
- Article
Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00749-0
- By:
- Publication type:
- Article
Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00744-5
- By:
- Publication type:
- Article
Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00742-7
- By:
- Publication type:
- Article
Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00729-4
- By:
- Publication type:
- Article
Ensuring equity with pre-clinical planning for chlamydia vaccines.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00726-7
- By:
- Publication type:
- Article
A next-generation GMMA-based vaccine candidate to fight shigellosis.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00725-8
- By:
- Publication type:
- Article
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00724-9
- By:
- Publication type:
- Article
Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00719-6
- By:
- Publication type:
- Article
The potential global cost-effectiveness of prospective Strep A vaccines and associated implementation efforts.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00718-7
- By:
- Publication type:
- Article
A Strep A vaccine global demand and return on investment forecast to inform industry research and development prioritization.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00690-2
- By:
- Publication type:
- Article
Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00772-1
- By:
- Publication type:
- Article
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00768-x
- By:
- Publication type:
- Article
Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00767-y
- By:
- Publication type:
- Article
IL6 suppresses vaccine responses in neonates by enhancing IL2 activity on T follicular helper cells.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00764-1
- By:
- Publication type:
- Article
Identification of the flavivirus conserved residues in the envelope protein hinge region for the rational design of a candidate West Nile live-attenuated vaccine.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00765-0
- By:
- Publication type:
- Article
Advancements in Rift Valley fever vaccines: a historical overview and prospects for next generation candidates.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00769-w
- By:
- Publication type:
- Article
Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00762-3
- By:
- Publication type:
- Article
Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00766-z
- By:
- Publication type:
- Article
Efficacy and safety in mice of repeated, lifelong administration of an ANGPTL3 vaccine.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00770-3
- By:
- Publication type:
- Article
mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00771-2
- By:
- Publication type:
- Article
The full health, economic, and social benefits of prospective Strep A vaccination.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00758-z
- By:
- Publication type:
- Article
Helper T cell bias following tuberculosis chemotherapy identifies opportunities for therapeutic vaccination to prevent relapse.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00761-4
- By:
- Publication type:
- Article
A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00763-2
- By:
- Publication type:
- Article
The advances of adjuvants in mRNA vaccines.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00760-5
- By:
- Publication type:
- Article
Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00759-y
- By:
- Publication type:
- Article
Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00755-2
- By:
- Publication type:
- Article
Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00756-1
- By:
- Publication type:
- Article
A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00753-4
- By:
- Publication type:
- Article
Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00752-5
- By:
- Publication type:
- Article
A recombinant virus-like particle vaccine against adenovirus-7 induces a potent humoral response.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00754-3
- By:
- Publication type:
- Article
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00751-6
- By:
- Publication type:
- Article
Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00749-0
- By:
- Publication type:
- Article
Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccine.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00732-9
- By:
- Publication type:
- Article
Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00744-5
- By:
- Publication type:
- Article
COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00745-4
- By:
- Publication type:
- Article